Lisata Therapeutics Profit Margin

The latest profit margin for LSTA is -14621.0% as of June 2026. That compares with -1768.5% in the prior-year period — down 726.7% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Lisata Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, LSTA's profit margin moved from -1768.5% to -14621.0% — a 726.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lisata Therapeutics's valuation or profitability profile.

Against Healthcare companies, LSTA currently prints -14621.0% for profit margin, while the sector average sits near 10.58%. That is roughly 138288.6% below the sector mean. Large gaps often invite a closer look at Lisata Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Lisata Therapeutics converts resources into returns. At -14621.0%, LSTA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1768.5% in the prior-year period — down 726.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LSTA's profit margin (-14621.0%), review year-over-year change from -1768.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.